Reading between the lines in the MD&A 1Q26: KT Medical Service Public Company Limited (KTMS)
Reading between the lines in the 1Q26 Management Discussion and Analysis of KT Medical Service Public Company Limited (KTMS): Revenue up 3.2%. Net profit down 35.3%. And a subsidiary covenant breach that does not appear in the FY25 MD&A.
The numbers
Revenue grows, but the mix shifts inside
KT Medical Service provides hemodialysis services through a network of stand-alone clinics and hospital-based units, supported by subsidiaries in water purification systems, dialysis concentrate, and pneumatic tube installation. In 1Q26, total revenue rose 3.2% YoY to Bt175m. Hemodialysis grew 9.5% YoY to Bt154m, lifting its share to 88.4% of the total. Water purification revenue fell 29.6% YoY to Bt16m, driven by the absence of any center decoration projects in 1Q26 and lower water system installation volumes.
Margins flat, costs spike, net profit falls hard
Gross margin was 18.4% in 1Q26, broadly in line with 19.0% in 1Q25. The margin held, but operating costs moved sharply. Administrative expenses rose 30.1% YoY to Bt21m, attributed to a financial advisory fee incurred by KTMS and an inventory write-off at a subsidiary. With costs absorbing the revenue gain, net profit fell 35.3% YoY to Bt7.3m, a net margin of 4.2%.
Liabilities ease, collateral structure changes
Total liabilities fell 2.1% to Bt290m from Bt297m at FY25. Long-term bank loans declined by Bt5m from scheduled repayments. One structural change in the collateral arrangements is also noted: restricted bank deposits fell by Bt10m, as KTMS replaced cash held as security for credit facilities with other forms of collateral.
What the numbers don’t show
Comparing the FY25 MD&A with 1Q26, a couple of things stand out.
A subsidiary covenant breach appears for the first time
The FY25 MD&A, filed in February 2026, covering the full year 2025, makes no mention of covenant risk at any subsidiary. The 1Q26 MD&A discloses that a subsidiary was unable to comply with all three financial covenants assessed under its bank loan agreements based on the FY25 audited financials: its D/E ratio stood at 2.37x against a 1.50x ceiling, its current ratio at 0.21x against a 1.00x floor, and its debt service coverage ratio at 0.07x against a 1.10x floor. The company states that the subsidiary has historically been loss-making, is now returning to operating profit, and has no overdue installments. It also asserts that this does not constitute an event of default. The FY25 MD&A’s narrative on administrative expenses cites only branch preparation costs and lease depreciation, with no reference to any subsidiary under financial stress.
Branch expansion guidance from FY25 was met partially on machines, not on branches
In the FY25 MD&A’s forward guidance section, KTMS stated it expected to open 1–2 new branches and add 18–42 hemodialysis machines in 1Q26, subject to the economic environment. The 1Q26 MD&A reports the group at 36 branches and 525 machines — unchanged in branch count from the 36 branches reported at FY25, and 14 new machines added. Zero new branches were opened against a stated expectation of 1–2, and the 14 machines added fall below the guided range of 18–42.